Kim Lauper - Concepedia

Author

Kim Lauper

University Hospital of Geneva ORCID

Also Known As

K Lauper, K. Lauper, Kim Lauper, Lauper, K, Lauper, Kim, Manouk de Hooge, Stéphane Genevay

112

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Geneva University of Geneva Diakonhjemmet Hospital University of Manchester University of Bari Aldo Moro

About

Kim Lauper is an author at University Hospital of Geneva specializing in autoimmunity, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	66
2	Immunology	3	3	66
3	Autoimmune Disease	2	2	41
4	Epidemiology	1	1	25
5	Rheumatology	1	1	25

Kim Lauper

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Annals of the Rheumatic Diseases	2022	1.6K
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration Kim Lauper, Michele Iudici, Denis Mongin, Annals of the Rheumatic Diseases	2022	138
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study Natacha Madelon, Kim Lauper, Gautier Bréville, Clinical Infectious Diseases	2021	122
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries Delphine S. Courvoisier, Katerina Chatzidionysiou, Denis Mongin, Lara D. Veeken	2020	90
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab Natacha Madelon, Nelli Heikkilä, Irène Sabater Royo, JAMA Neurology	2022	86
Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis Kim Lauper, Delphine S. Courvoisier, Paola Chevallier, Arthritis Care & Research	2018	74
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration Kim Lauper, Dan Nordström, Karel Pavelká, Annals of the Rheumatic Diseases	2018	70
After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries Manuel Pombo‐Suárez, Carlos Sánchez‐Piedra, Juan J. Gómez‐Reino, Annals of the Rheumatic Diseases	2022	44
One‐year persistent symptoms and functional impairment in SARS‐CoV‐2 positive and negative individuals Mayssam Nehme, Olivia Braillard, François Chappuis, Journal of Internal Medicine	2022	37
Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique? Denis Mongin, Kim Lauper, Carl Turesson, RMD Open	2019	35

Page 1